SINGAPORE (June 26): Clearbridge Health (CBH) is partnering Australia-based health information company Genome.One, a wholly-owned subsidiary of Garvan Institute of Medical Research, to offer its patients genomic testing and analysis with the latter’s Genome.One GoExplore personal health genomics programme.

The programme sequences and analyses individual DNA samples assess their risk of developing 52 hereditary conditions, including 31 cancers, 13 heart conditions, as well as several other conditions where monitoring or intervention can be of benefit.

The test will also determine patients’ likely response to over 220 different types of medication.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook